Le Lézard
Classified in: Health
Subjects: PER, PET

VCA Animal Hospital's Todd Lavender, DVM, Transitions to Role as Chief Transformation Officer for Mars Veterinary Health as Patty Wu Joins as New VCA President


Summary:

LOS ANGELES, May 2, 2024 /PRNewswire/ -- VCA Animal Hospitals, the global leader of comprehensive veterinary services and proudly part of Mars Veterinary Health, today announced the appointment of Patty Wu as president, effective May 2024. Patty succeeds Todd Lavender, DVM, who, following a successful 20 years at VCA, will become Chief Transformation Officer of Mars Veterinary Health.

"I've had the pleasure of working alongside Dr. Lavender for many years, and throughout this time, he's encouraged our teams to lead in medical quality, spread the joy of our profession and innovate for our clients," said Doug Drew, president, Mars Veterinary Health. "As Chief Transformation Officer, Todd will sharpen our future focus across our network, continuing to do more today to improve the experience of pet ownership and the experience of those caring for pets tomorrow." 

Drew continued: "I'm thrilled to welcome Patty to VCA and the Mars Veterinary Health family. As an accomplished senior executive with more than 20 years of experience leading and growing CPG, omni retail, and direct-to-consumer businesses in the U.S., Canada, China and Asia Pacific, Patty believes exceptional client and patient outcomes grow from a strong Associate and client experience."

Patty comes with a track record of strong execution and consistent focus on the Associate and client experience across categories ranging from health and wellness to baby and children, and personal care. She has held senior roles at companies including Bed, Bath & Beyond, where she served as EVP and Brand President for buybuy BABY, as well as The Honest Company, The Clorox Company, Walmart, Mattel, and Beautycounter.

Patty commented: "Over the past few years, VCA has expanded access to care, experienced amazing growth and stayed true to an Associate-first, pet-centric culture. I am excited and honored to join an organization with such clarity of mission and purpose."

As Chief Transformation Officer, Dr. Lavender will lead programs designed to increase access to care and inspire the next generation of veterinary professionals.

Reflecting on VCA, Dr. Lavender adds: "We are serious about our obligation of taking care of the future of veterinary medicine. We have expanded access to care across the U.S., and to Canada and Brazil, strengthened the Associate experience and continued to scale the highest-quality medicine for our patients. Patty is joining a network of hometown hospitals that puts patient outcomes, compassion and client experience at the center of everything we do. We welcome Patty to VCA."

About VCA Animal Hospitals 

A leader in veterinary care, VCA Animal Hospitals is committed to caring for the future of veterinary medicine. We are a family of hometown animal hospitals determined to positively impact pets, people, and our communities. From general practice to emergency and specialty care, VCA delivers world-class medicine to more than four million pets each year. Our national network of hospitals invest in cutting-edge tools, training and technology that enables our Associates to lead the industry today and into tomorrow. Among our talented 35,000 Associates are nearly 7,000 veterinarians ? including 430 who are board-certified specialists ? nearly 4,000 credentialed veterinary technicians and more than 10,000 veterinary assistants ? all dedicated to giving pets the very best in medical care.  

As part of the Mars Veterinary Health family of businesses, VCA is committed to its Purpose: A Better World for Pets®. To learn more about VCA, visit www.vca.com 

SOURCE VCA Animal Hospitals


These press releases may also interest you

at 19:30
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 12:18
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)



News published on and distributed by: